Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120705686 | 12070568 | 6 | F | 20160123 | 20160829 | 20160211 | 20160906 | EXP | US-JNJFOC-20160208429 | PHARMACYCLICS | 82.66 | YR | E | F | Y | 0.00000 | 20160906 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120705686 | 12070568 | 1 | SS | IMBRUVICA | IBRUTINIB | 1 | Oral | 28980 | MG | Y | U | 0 | 420 | MG | CAPSULE | QD | |||
| 120705686 | 12070568 | 2 | SS | IMBRUVICA | IBRUTINIB | 1 | Oral | 28980 | MG | Y | U | 0 | 280 | MG | CAPSULE | QD | |||
| 120705686 | 12070568 | 3 | PS | IMBRUVICA | IBRUTINIB | 1 | Oral | 28980 | MG | Y | U | 205552 | 420 | MG | CAPSULE | QD | |||
| 120705686 | 12070568 | 4 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | Y | 0 | 500 | MG | QD | |||||||
| 120705686 | 12070568 | 5 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 120705686 | 12070568 | 6 | C | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Oral | 0 | 6 | MG | QD | ||||||||
| 120705686 | 12070568 | 7 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 2760 | MG | 0 | 20 | MG | |||||||
| 120705686 | 12070568 | 8 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 2760 | MG | 0 | 40 | MG | QD | ||||||
| 120705686 | 12070568 | 9 | C | VANCOMYCIN | VANCOMYCIN | 1 | 0 | ||||||||||||
| 120705686 | 12070568 | 10 | C | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 120705686 | 12070568 | 11 | C | ONDANSETRON | ONDANSETRON | 1 | 0 | ||||||||||||
| 120705686 | 12070568 | 12 | C | ELIQUIS | APIXABAN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120705686 | 12070568 | 1 | Chronic lymphocytic leukaemia |
| 120705686 | 12070568 | 2 | Chronic lymphocytic leukaemia |
| 120705686 | 12070568 | 3 | Chronic lymphocytic leukaemia |
| 120705686 | 12070568 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120705686 | 12070568 | HO |
| 120705686 | 12070568 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120705686 | 12070568 | Anaemia | |
| 120705686 | 12070568 | Deep vein thrombosis | |
| 120705686 | 12070568 | Disease progression | |
| 120705686 | 12070568 | Drug hypersensitivity | |
| 120705686 | 12070568 | Hepatitis | |
| 120705686 | 12070568 | Pneumonia viral | |
| 120705686 | 12070568 | Pruritus | |
| 120705686 | 12070568 | Pulmonary embolism | |
| 120705686 | 12070568 | Pyelonephritis | |
| 120705686 | 12070568 | Rhinovirus infection | |
| 120705686 | 12070568 | Sepsis | |
| 120705686 | 12070568 | Upper respiratory tract infection | |
| 120705686 | 12070568 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120705686 | 12070568 | 1 | 20160504 | 20160624 | 0 | |
| 120705686 | 12070568 | 2 | 20160420 | 20160503 | 0 | |
| 120705686 | 12070568 | 3 | 20151203 | 20160109 | 0 | |
| 120705686 | 12070568 | 4 | 20160121 | 2016 | 0 | |
| 120705686 | 12070568 | 5 | 20160106 | 0 | ||
| 120705686 | 12070568 | 6 | 20151118 | 0 | ||
| 120705686 | 12070568 | 7 | 20160221 | 0 | ||
| 120705686 | 12070568 | 8 | 20151212 | 20160220 | 0 |